Certified by Founder Lodge
Metsera
United States - New York
START UP
1 Disclosed Funding Rounds $215,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Metsera is a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases. Metsera is advancing a broad portfolio of oral and inje
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| November, 14 ,2024 | Series B | $215,000,000 |
Viking Global Investors
Wellington Management
T. Rowe Price
Janus Henderson Investors
Newpath Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Allos | $5,000,000 | (Jan 14, 2026)
Nodu | $1,450,000 | (Jan 14, 2026)
Diagonal Therapeutics | $125,000,000 | (Jan 13, 2026)
BlueNalu | $11,000,000 | (Jan 13, 2026)
encoord | $2,000,000 | (Jan 13, 2026)
